600196 复星医药
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,055,6804,476,9813,414,2174,217,5713,937,815
投资活动产生之现金流量净额(185,091)(3,613,323)(3,819,290)(4,064,038)(3,857,489)
筹资活动产生之现金流量净额(633,627)(1,002,586)(1,336,250)4,428,475(819,407)
汇率变动对现金及现金等价物的影响8,91227,98973,645128,342(134,712)
现金及现金等价物净增加/(减少)245,874(110,939)(1,667,678)4,710,350(873,794)
期初现金及现金等价物余额9,391,4509,502,38911,170,0676,459,7177,333,511
期末现金及现金等价物余额9,637,3239,391,4509,502,38911,170,0676,459,717